Popular Joint Supplement Cuts Nephropathy Risk in T2D
TOPLINE: Regular use of glucosamine, a widely used supplement to manage osteoarthritis and joint pain, was linked to reduced risks for both composite microvascular complications and diabetic nephropathy among patients with type 2 diabetes (T2D). METHODOLOGY: Glucosamine, used daily by about 20% of US and Australian adults to treat osteoarthritis and joint pain, has been … Read more